Role of mitochondrial dysfunction in cardiac glycoside toxicity.

Role of mitochondrial dysfunction in cardiac glycoside toxicity.
复制标题

DOI:
10.1016/j.yjmcc.2010.06.012
复制
发表时间:
2010-11
影响因子:
5
通讯作者:
O'Rourke B
O'Rourke B
中科院分区:
医学2区
文献类型:
--
作者:
Liu T;Brown DA;O'Rourke B

文献摘要

参考文献

被引文献

相似文献

Cardiac glycosides, which inhibit the plasma membrane Na+ pump, are one of the four categories of drug recommended for routine use to treat heart failure, yet their therapeutic window is limited by toxic effects. Elevated cytoplasmic Na+ ([Na+]i) compromises mitochondrial energetics and redox balance by blunting mitochondrial Ca2+ ([Ca2+]m) accumulation, and this impairment can be prevented by enhancing [Ca2+]m. Here, we investigate whether this effect underlies the toxicity and arrhythmogenic effects of cardiac glycosides and if these effects can be prevented by suppressing mitochondrial Ca2+ efflux, via inhibition of the mitochondrial Na+/Ca2+ exchanger (mNCE). In isolated cardiomyocytes, ouabain elevated [Na+]i in a dose-dependent way, blunted [Ca2+]m accumulation, decreased the NADH/NAD+ redox potential, and increased reactive oxygen species (ROS). Concomitant treatment with the mNCE inhibitor CGP-37157 ameliorated these effects. CGP-37157 also attenuated ouabain-induced cellular Ca2+ overload and prevented delayed afterdepolarizations (DADs). In isolated perfused hearts, ouabain’s positive effects on contractility and respiration were markedly potentiated by CGP-37157, as were those mediated by β-adrenergic stimulation. Furthermore, CGP-37157 inhibited the arrhythmogenic effects of ouabain in both isolated perfused heart and in vivo. The findings reveal the mechanism behind cardiac glycoside toxicity and show that improving mitochondrial Ca2+ retention by mNCE inhibition can mitigate these effects, particularly with respect to the suppression of Ca2+-triggered arrhythmias, while enhancing positive inotropic actions. These results suggest a novel strategy for the treatment of heart failure.
DOI: 10.1016/0002-9343(83)90346-7
发表时间: 1983-01-01
影响因子: 5.9
作者:
COVIT, AB;SCHAER, GL;CODY, RJ
通讯作者: CODY, RJ
DOI: 10.1083/jcb.145.4.795
发表时间: 1999-05-17
期刊: The Journal of cell biology
影响因子: --
作者:
Boitier E;Rea R;Duchen MR
通讯作者: Duchen MR
DOI: 10.1016/j.ddmod.2007.11.003
发表时间: 2007-01-01
期刊: Drug discovery today. Disease models
影响因子: --
作者:
O'Rourke, Brian;Maack, Christoph
通讯作者: Maack, Christoph
DOI: 10.1093/cvr/22.9.656
发表时间: 1988-09-01
影响因子: 10.8
作者:
CURTIS, MJ;WALKER, MJA
通讯作者: WALKER, MJA
DOI: 10.1056/nejm199307013290101
发表时间: 1993-07-01
影响因子: 158.5
作者:
PACKER, M;GHEORGHIADE, M;JOLLY, MK
通讯作者: JOLLY, MK